Yield of routine imaging after curative colorectal cancer treatment

Acta Chirurgica Belgica

Volumn 108, Issue 1, 2008, Pages 88-92

  Jochmans, I ^a   Topal, B ^a   D'Hoore, A ^a   Aerts, R ^a   Vanbeckevoort, D ^a   Bielen, D ^a   Haustermans, K ^a   Van Cutsem, E ^a   Penninckx, F ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Abdominal ultrasound; Carcinoembryonic antigen; Colorectal cancer; Diagnostic imaging; Metastasis; Recurrence

Indexed keywords

EID: 40949085254     PISSN: 00015458     EISSN: 25770160     Source Type: Journal    
DOI: 10.1080/00015458.2008.11680182     Document Type: Article

References (40)

1. DESCH C. E., BENSON III A. B., SMITH T. J. et al. Recommended Colorectal Cancer Surveillance Guidelines by the American Society of Clinical Oncology. J Clin Oncol, 1999, 17: 1312-21.
2. KIEVIT J. Follow-up of patients with colorectal cancer: numbers needed to test and treat. Eur J Cancer, 2002, 38: 986-99.
3. GUNDERSON L. L., SARGENT D. J., TEPPER J. E. et al. Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer. A pooled analysis. J Clin Oncol, 2004, 22: 1785-96.
4. SARGENT D. J., WIEAND S., HALLER D. G. et al. Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies : individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol, 2005, 23: 8664-70.
5. MOORE E., HEALD R. J., CECIL T. D., SHARPE G. D., SEXTON S., MORAN B. J. Almost all five year disease free survivors are cured following rectal cancer surgery, but longer term follow-up detects some late local and systemic recurrences. Colorectal Dis, 2005, 7: 403-5.
6. OHLSSON B., PÄLSSON B. Follow-up after colorectal cancer surgery. Acta Oncol, 2003, 42: 816-26.
7. GALANDIUK S., WIAND H. S., MOERTEL C. G. Patterns of recurrence after curative resection of carcinoma of the colon and rectum. Surg Gynaecol Obset, 1992, 174: 27-32.
8. BRAMHALL S. R., GUR U., COLDHAM C., BOWRY C., BUCKLES J. A. Liver resection for colorectal metastases. Ann R Coll Surg Engl, 2003, 85: 334-9.
9. TOPAL B., KAUFMAN L., AERTS R., PENNINCKX F. Patterns of failure following curative resection of colorectal liver metastases. Eur J Surg Oncol, 2003, 29: 248-53.
10. INOUE M., OHTA M., IUCHI K. et al. Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma. Ann Thorac Surg, 2004, 78: 238-44.
11. SAITO Y., OMIYA H., KOHNO K. et al. Pulmonary metastasectomy for 165 patients with colorectal carcinoma: a prognostic assessment. J Thorac Cardiovasc Surg, 2002, 124: 1007-13.
12. MCCORMACK P. M., GINSBERG R. J. Current management of colorectal metastases to lung. Chest Surg Clin N Am, 1998, 8: 119-26.
13. JEFFERY M., HICKEY B. E., HIDER P. N. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Oxford, United Kingdom, Cochrane Library, CD002200, 2007
14. RENEHAN A. G., EGGER M., SAUNDERS M. P., O'DWYER S. T. Impact on survival of intensive follow up after curative resection of colorectal cancer: systemic review and meta-analysis of randomised trials. BMJ, 2002, 324: 813-20.
15. FIGUEREDO A., RUMBLE R. B., MAROUN J. et al. Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer, 2003, 3: 26-38.
16. KJELDSEN B. J., KRONBORG O., FENGER C., JORGENSEN O. D. A prospective randomized study of follow-up after radical surgery for colorectal cancer. Br J Surg, 1997, 84: 666-9.
17. MAKELA J. T., LAITINEN S. O., KAIRALUOMA M. I. Five-year follow-up after radical surgery for colorectal cancer. Results of a prospective randomized trial. Arch Surg, 1995, 130: 1062-7.
18. OHLSSON B., BRELAND U., EKBERG H., GRAFFNER H., TRANBERG K. G. Follow-up after curative surgery for colorectal carcinoma. Randomized comparison with no follow-up. Dis Colon Rectum, 1995, 38: 619-26.
19. SCHOEMAKER D., BLACK R., GILES L., TOOULI J. Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients. Gastroenterology, 1998, 114: 7-14.
20. PIETRA N., SARLI L., COSTI R., OUCHEMI C., GRATTAROLA M., PERACCHIA A. Role of follow-up in management of local recurrences of colorectal cancer. A prospective, randomized study. Dis Colon Rectum, 1998, 41: 1127-33.
21. SECCO G. B., FARDELLI R., GIANQUINTO D. et al. Efficacy and cost of risk-adapted follow-up in patients after colorectal cancer surgery: a prospective, randomized and controlled trial. Eur J Surg Oncol, 2002, 28: 418-23.
22. RODRIGUEZ-MORANTA F., SALO J., ARCUSA A. et al. Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial. J Clin Oncol, 2006, 24: 386-93.
23. VAN CUTSEM E. J. D., KATAJA V. V. ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of colon cancer. Ann Oncol, 2005, 16 (suppl 1): i16-7.
24. TVEIT K. M., KATAJA V. V. ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of rectal cancer. Ann Oncol, 2005, 16 (suppl 1): i20-1.
25. ANTHONY T., SIMMANG C., HYMAN N. et al. Practice parameters of the surveillance and follow-up of patients with colon and rectal cancer. Dis Colon Rectum, 2004, 47: 807-17.
26. DESCH C. E., BENSON III A. B., SOMERFIELD M. R. et al. Colorectal cancer surveillance:, 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol, 2005, 23: 8512-9.
27. BOULIN M., LEJEUNE C., LE TEUFF G. et al. Patterns of surveillance practices after curative surgery for colorectal cancer in a French population. Dis Colon Rectum, 2005, 48: 1890-9.
28. UICC. TNM classification of malignant tumours. In: HERMANEK P., SOBIN L. H. (eds). Fourth edition, 2nd revision. Springer-Verlag, Berlin, 1992.
29. MOERTEL C. G., FLEMING T. R., MACD ONALD J. S., HALLER D. G., LAURIE J. A., TANGEN C. M. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA, 1993, 270: 943-7.
30. HOWELL J. D., WOTHERSPOON H., LEEN E., COOKE T. C., MCARDLE C. S. Evaluation of a follow-up program after curative resection for colorectal cancer. Br J Cancer, 1999, 79: 308-10.
31. WOLMARK N., ROCKETTE H., FISHER B. et al. The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03. J Clin Oncol, 1993, 11: 1879-87.
32. ANDRE T., BONI C., MOUNEDJI-BOUDIAF L. et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Eng J Med, 2004, 350: 2343-51.
33. WOLMARK N., WIEAND S., KUEBLER J. P., COLANGELO L., SMITH R. E. A phase III trial comparing FULV to FULV and oxaliplatin in stage II or III carcinoma of the colon: results of NSABP protocol C-07 (abstract). J Clin Oncol, 2005, 23: 1092s.
34. CHAU I., ALLEN M. J., CUNNINGHAM D. et al. The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer. J Clin Oncol, 2004, 22: 1420-9.
35. FUSAI G., DAVIDSON B. R. Management of colorectal liver metastases. Colorectal Disease, 2003, 5: 2-23.
36. NORDLINGER B., GUIGUET M., VAILLANT J. C. et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie. Cancer, 1996, 77: 1254-62.
37. VOGELSANG H., HAAS S., HIERHOLZER C., BERGER U., SIEWERT J. R., PRÄUER H. Factors influencing survival after resection of pulmonary metastases from colorectal cancer. Br J Surg, 2004, 91: 1066-71.
38. STELZNER S., HELLMICH G., KOCH R., LUDWIG K. Factors predicting survival in stage IV colorectal carcinoma patients after palliative treatment: a multivariate analysis. J Surg Oncol, 2005, 89: 211-7.
39. MCCORMACK P. M., GINSBERG R. J. Current management of colorectal metastases to lung. Chest Surg Clinics North Am, 1998, 8: 119-26.
40. Sakorafas G. H., Zouros E., Peros G. Applied vascular anatomy of the colon and rectum: clinical implications for the surgical oncologist. Surg Oncol, 2006, 15: 243-55.